25 XP   0   0   10

Theratechnologies Inc.
Buy, Hold or Sell?

Let's analyze Theratech together

I guess you are interested in Theratechnologies Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Theratechnologies Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Theratechnologies Inc.

I send you an email if I find something interesting about Theratechnologies Inc..

Quick analysis of Theratech (30 sec.)










What can you expect buying and holding a share of Theratech? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.53
Expected worth in 1 year
$-0.37
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$0.17
Return On Investment
12.5%

For what price can you sell your share?

Current Price per Share
$1.35
Expected price per share
$1.08 - $1.75
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Theratech (5 min.)




Live pricePrice per Share (EOD)

$1.35

Intrinsic Value Per Share

$-1.99 - $3.25

Total Value Per Share

$-2.53 - $2.72

2. Growth of Theratech (5 min.)




Is Theratech growing?

Current yearPrevious yearGrowGrow %
How rich?-$24.5m-$21.1m-$11m-34.3%

How much money is Theratech making?

Current yearPrevious yearGrowGrow %
Making money-$4.4m-$12.1m$7.6m171.0%
Net Profit Margin-25.0%-60.9%--

How much money comes from the company's main activities?

3. Financial Health of Theratech (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Theratech? (5 min.)

Welcome investor! Theratech's management wants to use your money to grow the business. In return you get a share of Theratech.

What can you expect buying and holding a share of Theratech?

First you should know what it really means to hold a share of Theratech. And how you can make/lose money.

Speculation

The Price per Share of Theratech is $1.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Theratech.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Theratech, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.53. Based on the TTM, the Book Value Change Per Share is $0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Theratech.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.10-7.1%-0.10-7.2%-0.26-19.4%-0.15-11.3%-0.09-6.7%
Usd Book Value Change Per Share-0.08-6.0%0.043.1%-0.23-17.1%-0.06-4.7%-0.02-1.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.08-6.0%0.043.1%-0.23-17.1%-0.06-4.7%-0.02-1.6%
Usd Price Per Share1.45-1.24-1.97-2.50-3.03-
Price to Earnings Ratio-3.76--6.56--2.20--6.38-1.03-
Price-to-Total Gains Ratio-18.03--68.61--11.80--35.95-61.69-
Price to Book Ratio-2.71--2.08--5.38-4.10-4.57-
Price-to-Total Gains Ratio-18.03--68.61--11.80--35.95-61.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.35
Number of shares740
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.04-0.06
Usd Total Gains Per Share0.04-0.06
Gains per Quarter (740 shares)31.15-47.23
Gains per Year (740 shares)124.61-188.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101251150-189-199
202492400-378-388
303743650-567-577
404984900-756-766
506236150-945-955
607487400-1134-1144
708728650-1322-1333
809979900-1511-1522
90112211150-1700-1711
100124612400-1889-1900

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%7.033.00.017.5%15.094.00.013.8%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%2.018.00.010.0%13.027.00.032.5%40.069.00.036.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0109.00.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%2.018.00.010.0%13.027.00.032.5%40.069.00.036.7%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Theratech

About Theratechnologies Inc.

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Fundamental data was last updated by Penke on 2024-06-19 08:48:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Theratechnologies Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Theratech earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • A Net Profit Margin of -27.6% means that $-0.28 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Theratechnologies Inc.:

  • The MRQ is -27.6%. The company is making a huge loss. -2
  • The TTM is -25.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-27.6%TTM-25.0%-2.6%
TTM-25.0%YOY-60.9%+35.9%
TTM-25.0%5Y-39.1%+14.1%
5Y-39.1%10Y-2,773.7%+2,734.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.6%-168.0%+140.4%
TTM-25.0%-209.9%+184.9%
YOY-60.9%-242.3%+181.4%
5Y-39.1%-401.7%+362.6%
10Y-2,773.7%-532.2%-2,241.5%
1.1.2. Return on Assets

Shows how efficient Theratech is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • -6.2% Return on Assets means that Theratech generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Theratechnologies Inc.:

  • The MRQ is -6.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.2%TTM-6.4%+0.2%
TTM-6.4%YOY-13.3%+7.0%
TTM-6.4%5Y-7.2%+0.8%
5Y-7.2%10Y-4.9%-2.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%-11.9%+5.7%
TTM-6.4%-11.9%+5.5%
YOY-13.3%-11.3%-2.0%
5Y-7.2%-13.5%+6.3%
10Y-4.9%-14.9%+10.0%
1.1.3. Return on Equity

Shows how efficient Theratech is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • 0.0% Return on Equity means Theratech generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Theratechnologies Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-115.0%+115.0%
5Y-115.0%10Y-62.5%-52.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.2%+14.2%
TTM--15.7%+15.7%
YOY--14.3%+14.3%
5Y-115.0%-19.2%-95.8%
10Y-62.5%-19.7%-42.8%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Theratechnologies Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Theratech is operating .

  • Measures how much profit Theratech makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • An Operating Margin of -13.8% means the company generated $-0.14  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Theratechnologies Inc.:

  • The MRQ is -13.8%. The company is operating very inefficient. -2
  • The TTM is -12.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM-12.2%-1.6%
TTM-12.2%YOY-46.8%+34.5%
TTM-12.2%5Y-29.1%+16.9%
5Y-29.1%10Y-2,441.0%+2,411.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.8%-354.6%+340.8%
TTM-12.2%-225.9%+213.7%
YOY-46.8%-252.2%+205.4%
5Y-29.1%-428.3%+399.2%
10Y-2,441.0%-531.1%-1,909.9%
1.2.2. Operating Ratio

Measures how efficient Theratech is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.14 means that the operating costs are $1.14 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Theratechnologies Inc.:

  • The MRQ is 1.138. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.119. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.138TTM1.119+0.020
TTM1.119YOY0.626+0.493
TTM1.1195Y-0.058+1.176
5Y-0.05810Y-12.266+12.209
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1383.004-1.866
TTM1.1193.332-2.213
YOY0.6263.502-2.876
5Y-0.0585.271-5.329
10Y-12.2666.915-19.181
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Theratechnologies Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Theratech is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.15 means the company has $1.15 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Theratechnologies Inc.:

  • The MRQ is 1.152. The company is just able to pay all its short-term debts.
  • The TTM is 0.906. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.152TTM0.906+0.246
TTM0.906YOY1.023-0.117
TTM0.9065Y1.688-0.783
5Y1.68810Y1.781-0.093
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1523.767-2.615
TTM0.9064.000-3.094
YOY1.0234.905-3.882
5Y1.6885.883-4.195
10Y1.7816.286-4.505
1.3.2. Quick Ratio

Measures if Theratech is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • A Quick Ratio of 1.10 means the company can pay off $1.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Theratechnologies Inc.:

  • The MRQ is 1.096. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.861. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.096TTM0.861+0.236
TTM0.861YOY0.815+0.046
TTM0.8615Y1.398-0.537
5Y1.39810Y1.412-0.014
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0963.054-1.958
TTM0.8613.506-2.645
YOY0.8154.756-3.941
5Y1.3985.757-4.359
10Y1.4126.338-4.926
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Theratechnologies Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Theratech assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Theratech to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.34 means that Theratech assets are financed with 134.1% credit (debt) and the remaining percentage (100% - 134.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Theratechnologies Inc.:

  • The MRQ is 1.341. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.487. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.341TTM1.487-0.146
TTM1.487YOY1.240+0.247
TTM1.4875Y1.034+0.453
5Y1.03410Y0.710+0.324
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3410.330+1.011
TTM1.4870.342+1.145
YOY1.2400.287+0.953
5Y1.0340.368+0.666
10Y0.7100.382+0.328
1.4.2. Debt to Equity Ratio

Measures if Theratech is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Theratechnologies Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y12.849-12.849
5Y12.84910Y7.176+5.673
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.365-0.365
TTM-0.415-0.415
YOY-0.370-0.370
5Y12.8490.443+12.406
10Y7.1760.476+6.700
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Theratechnologies Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Theratech generates.

  • Above 15 is considered overpriced but always compare Theratech to the Biotechnology industry mean.
  • A PE ratio of -3.76 means the investor is paying $-3.76 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Theratechnologies Inc.:

  • The EOD is -3.498. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.757. Based on the earnings, the company is expensive. -2
  • The TTM is -6.558. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.498MRQ-3.757+0.259
MRQ-3.757TTM-6.558+2.801
TTM-6.558YOY-2.198-4.360
TTM-6.5585Y-6.378-0.180
5Y-6.37810Y1.034-7.412
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.498-2.341-1.157
MRQ-3.757-2.997-0.760
TTM-6.558-2.882-3.676
YOY-2.198-3.553+1.355
5Y-6.378-6.262-0.116
10Y1.034-6.288+7.322
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Theratechnologies Inc.:

  • The EOD is -9.177. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.856. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.504. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.177MRQ-9.856+0.680
MRQ-9.856TTM-3.504-6.352
TTM-3.504YOY-10.516+7.012
TTM-3.5045Y-2.928-0.576
5Y-2.92810Y-12.931+10.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.177-2.932-6.245
MRQ-9.856-3.739-6.117
TTM-3.504-3.776+0.272
YOY-10.516-4.917-5.599
5Y-2.928-7.942+5.014
10Y-12.931-8.503-4.428
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Theratech is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -2.71 means the investor is paying $-2.71 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Theratechnologies Inc.:

  • The EOD is -2.527. Based on the equity, the company is expensive. -2
  • The MRQ is -2.714. Based on the equity, the company is expensive. -2
  • The TTM is -2.076. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.527MRQ-2.714+0.187
MRQ-2.714TTM-2.076-0.637
TTM-2.076YOY-5.384+3.308
TTM-2.0765Y4.098-6.174
5Y4.09810Y4.573-0.475
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.5271.843-4.370
MRQ-2.7142.249-4.963
TTM-2.0762.301-4.377
YOY-5.3842.412-7.796
5Y4.0983.782+0.316
10Y4.5734.212+0.361
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Theratechnologies Inc..

3.1. Institutions holding Theratechnologies Inc.

Institutions are holding 50.902% of the shares of Theratechnologies Inc..

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Soleus Capital Management, L.P.10.44230.863148013762470000105.946
2023-12-31AIGH Capital Management, LLC8.0892.383737193022915906362.9475
2024-03-31Nantahala Capital Management, LLC5.83350.25442682228-2682228-50
2024-03-31Morgan Stanley - Brokerage Accounts4.89830.00032252232-7168-0.3173
2023-12-31Worth Venture Partners, LLC1.97160.7937906557710551362.5149
2024-03-31Advisor Group Holdings, Inc.0.31510.00051448791682513.139
2024-03-31Stifel Financial Corp0.15650.00017197129134.2182
2024-03-31Sontag Advisory LLC0.11150.00115125000
2024-03-31Hamilton Capital Management Inc0.09590.00554407200
2024-03-31Summit Trail Advisors, LLC0.0720.001533090330900
2024-03-31Beacon Pointe Advisors, LLC0.05770.0005265255001.9212
2024-03-31Geode Capital Management, LLC0.055902568100
2023-12-31Creative Financial Designs Inc0.05440.00412500311254.7114
2023-12-31Bare Financial Services Inc0.0520.07823907239070
2023-12-31PNC Financial Services Group Inc0.047302174200
2024-03-31UBS Group AG0.0420192948114.3878
2024-03-31Bank of Montreal0.0397018262-28000-60.5248
2024-03-31BMO Capital Markets Corp.0.0397018262-28000-60.5248
2024-03-31Kohmann Bosshard Financial Services, LLC0.03350.00361540200
2024-03-31Greatmark Investment Partners Inc0.03240.00351487500
Total 32.44034.393614915910+3430232+23.0%

3.2. Funds holding Theratechnologies Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Fidelity Nasdaq Composite Index0.05590.00022568100
Total 0.05590.00022568100.0%
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Theratechnologies Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0800.042-291%-0.231+187%-0.064-21%-0.021-73%
Book Value Per Share---0.534-0.700+31%-0.460-14%0.056-1061%0.346-255%
Current Ratio--1.1520.906+27%1.023+13%1.688-32%1.781-35%
Debt To Asset Ratio--1.3411.487-10%1.240+8%1.034+30%0.710+89%
Debt To Equity Ratio----0%-0%12.849-100%7.176-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.096-0.098+1%-0.262+172%-0.153+59%-0.090-7%
Free Cash Flow Per Share---0.037-0.031-17%-0.081+122%-0.071+93%-0.032-13%
Free Cash Flow To Equity Per Share---0.0430.049-187%-0.019-55%-0.019-55%0.026-263%
Gross Profit Margin--2.2854.350-47%1.857+23%2.677-15%1.742+31%
Intrinsic Value_10Y_max--3.252--------
Intrinsic Value_10Y_min---1.994--------
Intrinsic Value_1Y_max---0.062--------
Intrinsic Value_1Y_min---0.269--------
Intrinsic Value_3Y_max--0.110--------
Intrinsic Value_3Y_min---0.752--------
Intrinsic Value_5Y_max--0.638--------
Intrinsic Value_5Y_min---1.172--------
Market Cap62073000.000-7%66671027.55056785306.888+17%90350700.000-26%115110931.378-42%139319400.689-52%
Net Profit Margin---0.276-0.250-9%-0.609+121%-0.391+42%-27.737+9957%
Operating Margin---0.138-0.122-12%-0.468+238%-0.291+111%-24.410+17557%
Operating Ratio--1.1381.119+2%0.626+82%-0.058+105%-12.266+1178%
Pb Ratio-2.527+7%-2.714-2.076-23%-5.384+98%4.098-166%4.573-159%
Pe Ratio-3.498+7%-3.757-6.558+75%-2.198-41%-6.378+70%1.034-464%
Price Per Share1.350-7%1.4501.235+17%1.965-26%2.504-42%3.030-52%
Price To Free Cash Flow Ratio-9.177+7%-9.856-3.504-64%-10.516+7%-2.928-70%-12.931+31%
Price To Total Gains Ratio-16.785+7%-18.028-68.607+281%-11.800-35%-35.950+99%61.689-129%
Quick Ratio--1.0960.861+27%0.815+35%1.398-22%1.412-22%
Return On Assets---0.062-0.064+4%-0.133+117%-0.072+17%-0.049-21%
Return On Equity----0%-0%-1.1500%-0.6250%
Total Gains Per Share---0.0800.042-291%-0.231+187%-0.064-21%-0.021-73%
Usd Book Value---24568203.000-32168300.750+31%-21146500.000-14%2557239.850-1061%15886619.825-255%
Usd Book Value Change Per Share---0.0800.042-291%-0.231+187%-0.064-21%-0.021-73%
Usd Book Value Per Share---0.534-0.700+31%-0.460-14%0.056-1061%0.346-255%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.096-0.098+1%-0.262+172%-0.153+59%-0.090-7%
Usd Free Cash Flow---1691082.000-1406520.500-17%-3746500.000+122%-3271154.100+93%-1462814.865-13%
Usd Free Cash Flow Per Share---0.037-0.031-17%-0.081+122%-0.071+93%-0.032-13%
Usd Free Cash Flow To Equity Per Share---0.0430.049-187%-0.019-55%-0.019-55%0.026-263%
Usd Market Cap62073000.000-7%66671027.55056785306.888+17%90350700.000-26%115110931.378-42%139319400.689-52%
Usd Price Per Share1.350-7%1.4501.235+17%1.965-26%2.504-42%3.030-52%
Usd Profit---4436615.000-4487653.750+1%-12162000.000+174%-7064530.750+59%-4150862.300-6%
Usd Revenue--16086073.00019485518.250-17%20352000.000-21%18095153.600-11%12769468.132+26%
Usd Total Gains Per Share---0.0800.042-291%-0.231+187%-0.064-21%-0.021-73%
 EOD+2 -6MRQTTM+16 -16YOY+18 -145Y+14 -1910Y+8 -25

4.2. Fundamental Score

Let's check the fundamental score of Theratechnologies Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.498
Price to Book Ratio (EOD)Between0-1-2.527
Net Profit Margin (MRQ)Greater than0-0.276
Operating Margin (MRQ)Greater than0-0.138
Quick Ratio (MRQ)Greater than11.096
Current Ratio (MRQ)Greater than11.152
Debt to Asset Ratio (MRQ)Less than11.341
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.062
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Theratechnologies Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.193
Ma 20Greater thanMa 501.312
Ma 50Greater thanMa 1001.293
Ma 100Greater thanMa 2001.366
OpenGreater thanClose1.362
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2024-02-29. Currency in USD. All numbers in thousands.

Summary
Total Assets71,991
Total Liabilities96,559
Total Stockholder Equity-24,568
 As reported
Total Liabilities 96,559
Total Stockholder Equity+ -24,568
Total Assets = 71,991

Assets

Total Assets71,991
Total Current Assets57,861
Long-term Assets14,130
Total Current Assets
Cash And Cash Equivalents 32,196
Short-term Investments 6,204
Net Receivables 10,481
Inventory 6,294
Other Current Assets 2,686
Total Current Assets  (as reported)57,861
Total Current Assets  (calculated)57,861
+/- 0
Long-term Assets
Property Plant Equipment 1,817
Intangible Assets 12,136
Long-term Assets Other 165
Long-term Assets  (as reported)14,130
Long-term Assets  (calculated)14,117
+/- 12

Liabilities & Shareholders' Equity

Total Current Liabilities50,246
Long-term Liabilities46,313
Total Stockholder Equity-24,568
Total Current Liabilities
Short-term Debt 12,767
Short Long Term Debt 12,354
Accounts payable 29,888
Other Current Liabilities 7,553
Total Current Liabilities  (as reported)50,246
Total Current Liabilities  (calculated)62,562
+/- 12,316
Long-term Liabilities
Long term Debt 45,895
Capital Lease Obligations 891
Long-term Liabilities Other 22
Long-term Liabilities  (as reported)46,313
Long-term Liabilities  (calculated)46,808
+/- 495
Total Stockholder Equity
Common Stock363,427
Retained Earnings -412,572
Accumulated Other Comprehensive Income 743
Other Stockholders Equity 23,834
Total Stockholder Equity (as reported)-24,568
Total Stockholder Equity (calculated)-24,568
+/-0
Other
Capital Stock363,927
Cash and Short Term Investments 38,400
Common Stock Shares Outstanding 45,980
Current Deferred Revenue38
Liabilities and Stockholders Equity 71,991
Net Debt 26,863
Net Invested Capital 33,647
Net Working Capital 7,626
Property Plant and Equipment Gross 1,819
Short Long Term Debt Total 59,059



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302012-08-312012-05-312012-02-292011-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302009-08-312009-05-312009-02-282008-11-302008-08-312008-05-312008-02-292007-11-302007-08-312007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312005-05-312005-02-282004-11-302004-08-312004-05-312004-02-292003-11-302003-08-312003-05-312003-02-282002-11-302002-08-312002-05-312002-02-282001-11-302001-08-312001-05-312001-02-282000-11-302000-08-312000-05-312000-02-291999-11-301999-08-311999-05-311999-02-281998-11-301998-08-311998-05-311998-02-281997-11-301997-08-311997-05-311997-02-28
> Total Assets 
11,399
10,086
9,719
8,503
7,518
13,868
12,782
12,435
11,734
15,124
18,869
18,336
20,192
41,045
47,972
54,992
52,977
53,266
93,270
90,376
102,568
99,192
95,019
89,781
88,915
89,059
83,369
72,875
77,593
69,845
58,540
57,227
63,114
50,861
49,040
45,931
43,203
57,126
51,396
44,650
84,561
85,365
80,143
74,553
94,425
84,276
68,156
43,115
61,968
65,036
68,107
65,381
58,880
54,835
47,868
70,279
66,438
62,965
57,802
51,204
46,006
41,601
41,406
36,574
32,455
28,700
25,710
23,457
19,121
34,281
30,242
28,617
29,064
30,517
39,126
37,576
37,631
39,770
38,621
39,445
52,085
56,149
58,214
59,138
56,396
54,081
107,759
111,116
116,490
110,635
108,070
117,555
110,667
111,754
101,504
100,142
135,080
133,523
127,002
119,212
108,670
95,359
95,855
93,260
79,240
68,733
56,686
77,769
71,991
71,99177,76956,68668,73379,24093,26095,85595,359108,670119,212127,002133,523135,080100,142101,504111,754110,667117,555108,070110,635116,490111,116107,75954,08156,39659,13858,21456,14952,08539,44538,62139,77037,63137,57639,12630,51729,06428,61730,24234,28119,12123,45725,71028,70032,45536,57441,40641,60146,00651,20457,80262,96566,43870,27947,86854,83558,88065,38168,10765,03661,96843,11568,15684,27694,42574,55380,14385,36584,56144,65051,39657,12643,20345,93149,04050,86163,11457,22758,54069,84577,59372,87583,36989,05988,91589,78195,01999,192102,56890,37693,27053,26652,97754,99247,97241,04520,19218,33618,86915,12411,73412,43512,78213,8687,5188,5039,71910,08611,399
   > Total Current Assets 
10,960
9,578
9,359
7,730
6,745
12,907
11,896
11,523
10,739
14,107
16,928
16,434
18,194
31,635
22,453
20,983
14,976
19,351
41,584
35,339
41,222
33,603
28,480
28,483
38,065
42,717
36,608
32,760
39,791
28,604
14,603
17,553
20,059
19,193
18,298
14,720
14,345
19,939
20,544
18,817
60,219
35,856
36,496
34,420
46,945
38,753
27,578
11,418
17,683
20,710
26,496
15,239
14,219
15,540
9,673
33,888
18,670
19,207
18,267
17,846
20,218
18,726
19,556
17,202
15,317
16,067
14,007
12,331
10,080
14,597
12,930
15,296
16,206
18,093
27,111
25,823
22,972
20,138
19,670
21,163
33,522
30,436
31,817
34,567
33,315
32,416
68,004
73,606
72,486
69,156
68,810
76,181
68,795
72,163
63,994
64,807
101,859
102,439
97,767
91,908
83,490
78,302
77,872
73,370
60,936
51,129
40,565
63,297
57,861
57,86163,29740,56551,12960,93673,37077,87278,30283,49091,90897,767102,439101,85964,80763,99472,16368,79576,18168,81069,15672,48673,60668,00432,41633,31534,56731,81730,43633,52221,16319,67020,13822,97225,82327,11118,09316,20615,29612,93014,59710,08012,33114,00716,06715,31717,20219,55618,72620,21817,84618,26719,20718,67033,8889,67315,54014,21915,23926,49620,71017,68311,41827,57838,75346,94534,42036,49635,85660,21918,81720,54419,93914,34514,72018,29819,19320,05917,55314,60328,60439,79132,76036,60842,71738,06528,48328,48033,60341,22235,33941,58419,35114,97620,98322,45331,63518,19416,43416,92814,10710,73911,52311,89612,9076,7457,7309,3599,57810,960
       Cash And Cash Equivalents 
9,645
7,981
8,351
6,957
5,691
11,328
10,251
10,352
9,347
13,157
15,991
272
1,930
12,147
11,757
883
1,174
7,125
20,517
1,552
13,062
7,105
9,568
125
3,332
4,357
1,901
41
15,942
2,634
346
367
4,500
6,056
4,015
931
62
1,549
1,399
14
47,005
11,825
6,193
2,577
17,741
8,028
9,051
107
5,428
3,517
11,618
1,436
3,170
3,314
2,235
26,139
544
1,034
516
2,478
63
1,011
2,562
1,522
77
390
1,539
913
214
285
2,324
608
3,169
3,657
11,448
11,517
8,363
3,612
244
789
5,467
3,015
1,031
1,364
1,355
2,335
34,241
38,997
40,194
30,089
31,034
28,661
23,600
21,440
17,242
12,737
49,116
38,235
32,446
20,399
14,342
13,200
23,416
23,856
20,023
16,957
14,966
34,097
32,196
32,19634,09714,96616,95720,02323,85623,41613,20014,34220,39932,44638,23549,11612,73717,24221,44023,60028,66131,03430,08940,19438,99734,2412,3351,3551,3641,0313,0155,4677892443,6128,36311,51711,4483,6573,1696082,3242852149131,539390771,5222,5621,011632,4785161,03454426,1392,2353,3143,1701,43611,6183,5175,4281079,0518,02817,7412,5776,19311,82547,005141,3991,549629314,0156,0564,5003673462,63415,942411,9014,3573,3321259,5687,10513,0621,55220,5177,1251,17488311,75712,1471,93027215,99113,1579,34710,35210,25111,3285,6916,9578,3517,9819,645
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
14,872
14,403
17,553
9,174
17,861
11,463
9,987
18,715
31,254
24,038
22,478
14,686
24,984
30,226
33,623
31,055
30,280
21,031
22,576
11,694
14,749
12,922
9,305
9,931
10,715
10,725
14,150
14,888
15,789
9,093
18,632
25,321
27,452
24,977
26,477
15,891
8,821
7,708
11,721
8,730
9,489
5,959
5,016
1,598
1,824
10,558
6,737
1,185
728
3,611
156
828
150
111
110
69
93
49
37
32
2,177
0
0
0
0
16
21
3,202
4,947
13,287
10,900
13,588
16,513
17,486
10,725
10,732
9,691
9,826
10,122
10,933
11,964
10,979
10,203
9,605
8,223
7,600
18,479
19,138
22,979
19,941
19,291
13,046
9,214
9,133
8,412
7,908
6,290
6,204
6,2046,2907,9088,4129,1339,21413,04619,29119,94122,97919,13818,4797,6008,2239,60510,20310,97911,96410,93310,1229,8269,69110,73210,72517,48616,51313,58810,90013,2874,9473,202211600002,17732374993691101111508281563,6117281,1856,73710,5581,8241,5985,0165,9599,4898,73011,7217,7088,82115,89126,47724,97727,45225,32118,6329,09315,78914,88814,15010,72510,7159,9319,30512,92214,74911,69422,57621,03130,28031,05533,62330,22624,98414,68622,47824,03831,25418,7159,98711,46317,8619,17417,55314,40314,87200000000000
       Net Receivables 
877
1,161
720
703
984
1,373
1,455
781
1,061
610
468
1,019
1,585
1,535
1,131
1,544
1,576
1,169
1,256
1,376
2,755
2,484
2,190
1,753
1,653
1,776
773
1,217
1,485
1,938
1,218
968
1,152
1,268
1,533
1,058
1,331
1,487
1,699
1,927
1,830
2,235
1,808
1,868
2,287
2,945
1,919
1,928
2,372
2,890
3,092
1,615
2,012
2,064
608
484
1,920
2,347
3,255
2,063
769
1,660
412
1,600
1,265
2,094
694
461
263
3,979
70
2,059
2,029
3,341
4,564
3,441
4,340
5,570
5,304
4,994
4,587
5,935
6,788
7,553
5,090
7,826
11,637
10,952
7,986
13,421
11,374
10,116
9,886
12,191
8,475
13,185
11,236
10,827
13,513
10,964
13,948
12,853
11,530
12,344
10,383
13,603
9,115
13,551
10,481
10,48113,5519,11513,60310,38312,34411,53012,85313,94810,96413,51310,82711,23613,1858,47512,1919,88610,11611,37413,4217,98610,95211,6377,8265,0907,5536,7885,9354,5874,9945,3045,5704,3403,4414,5643,3412,0292,059703,9792634616942,0941,2651,6004121,6607692,0633,2552,3471,9204846082,0642,0121,6153,0922,8902,3721,9281,9192,9452,2871,8681,8082,2351,8301,9271,6991,4871,3311,0581,5331,2681,1529681,2181,9381,4851,2177731,7761,6531,7532,1902,4842,7551,3761,2561,1691,5761,5441,1311,5351,5851,0194686101,0617811,4551,3739847037201,161877
       Inventory 
219
218
144
70
70
69
127
260
199
136
67
68
69
200
194
491
569
836
876
730
967
1,156
1,475
1,274
2,374
2,397
2,264
763
681
664
1,057
1,299
1,255
2,088
2,230
1,652
1,787
2,174
2,048
745
1,858
2,446
2,265
2,109
1,184
596
240
242
1,256
1,462
1,455
2,104
2,142
4,261
4,324
4,234
4,718
8,004
10,827
10,006
13,651
13,789
14,019
12,874
12,973
12,338
10,763
10,381
9,026
9,333
9,652
9,305
9,412
9,903
9,641
9,532
8,929
9,640
9,624
9,133
8,666
8,826
8,282
7,239
7,369
8,575
8,581
11,084
11,502
12,861
12,860
20,929
20,670
24,735
25,669
25,145
27,344
28,578
27,293
29,141
26,134
24,976
23,141
19,688
15,110
9,162
6,723
6,066
6,294
6,2946,0666,7239,16215,11019,68823,14124,97626,13429,14127,29328,57827,34425,14525,66924,73520,67020,92912,86012,86111,50211,0848,5818,5757,3697,2398,2828,8268,6669,1339,6249,6408,9299,5329,6419,9039,4129,3059,6529,3339,02610,38110,76312,33812,97312,87414,01913,78913,65110,00610,8278,0044,7184,2344,3244,2612,1422,1041,4551,4621,2562422405961,1842,1092,2652,4461,8587452,0482,1741,7871,6522,2302,0881,2551,2991,0576646817632,2642,3972,3741,2741,4751,156967730876836569491194200696867136199260127697070144218219
       Other Current Assets 
219
218
144
0
0
137
63
130
133
203
401
204
207
200
196
205
195
233
221
427
399
380
561
347
-1
563
615
460
652
791
288
170
232
476
588
364
442
579
509
343
432
718
909
414
757
707
476
320
560
639
940
596
257
257
267
1,207
929
1,084
2,484
2,571
2,123
6
1,735
1,604
1,428
1,982
996
523
528
4,806
852
1,198
246
1,211
1,464
1,414
1,318
1,317
1,306
1,325
1,545
1,775
2,055
1,997
2,030
3,008
2,895
3,114
2,978
2,663
2,609
5,089
3,660
3,594
3,202
7,755
6,563
6,320
5,377
11,523
9,125
7,982
6,739
8,268
6,287
2,995
1,853
3,293
2,686
2,6863,2931,8532,9956,2878,2686,7397,9829,12511,5235,3776,3206,5637,7553,2023,5943,6605,0892,6092,6632,9783,1142,8953,0082,0301,9972,0551,7751,5451,3251,3061,3171,3181,4141,4641,2112461,1988524,8065285239961,9821,4281,6041,73562,1232,5712,4841,0849291,207267257257596940639560320476707757414909718432343509579442364588476232170288791652460615563-13475613803994272212331952051962002072044012031331306313700144218219
   > Long-term Assets 
438
508
360
773
773
961
886
911
994
1,017
1,940
1,901
1,999
9,410
25,519
34,010
38,001
33,916
51,686
55,037
61,346
65,590
66,539
61,298
50,850
46,342
46,762
40,115
37,803
41,241
43,937
39,674
43,054
31,668
30,742
31,211
28,858
37,187
30,852
25,833
24,342
49,509
43,647
40,133
47,480
45,523
40,578
31,697
44,286
44,326
41,611
50,143
44,661
39,295
38,195
36,391
47,768
43,758
39,535
33,358
25,789
22,875
21,850
19,372
17,138
12,634
11,703
11,126
8,662
19,684
17,312
13,321
12,858
12,424
12,015
11,753
14,659
19,632
18,952
18,282
18,562
25,714
26,397
24,572
23,082
21,664
21,488
37,510
28,137
26,833
25,835
41,374
41,872
29,828
28,967
35,335
33,221
31,084
28,894
26,683
24,531
16,410
17,983
19,890
18,304
17,604
16,121
14,472
14,130
14,13014,47216,12117,60418,30419,89017,98316,41024,53126,68328,89431,08433,22135,33528,96729,82841,87241,37425,83526,83328,13737,51021,48821,66423,08224,57226,39725,71418,56218,28218,95219,63214,65911,75312,01512,42412,85813,32117,31219,6848,66211,12611,70312,63417,13819,37221,85022,87525,78933,35839,53543,75847,76836,39138,19539,29544,66150,14341,61144,32644,28631,69740,57845,52347,48040,13343,64749,50924,34225,83330,85237,18728,85831,21130,74231,66843,05439,67443,93741,24137,80340,11546,76246,34250,85061,29866,53965,59061,34655,03751,68633,91638,00134,01025,5199,4101,9991,9011,9401,017994911886961773773360508438
       Property Plant Equipment 
365
363
288
281
351
481
380
391
398
407
468
407
551
801
681
957
1,246
1,274
1,329
1,737
2,454
4,144
4,547
4,824
5,073
5,064
4,726
4,102
3,801
3,509
1,514
7,032
1,753
1,817
1,869
6,679
1,722
1,675
1,538
1,384
1,408
1,539
1,629
1,721
1,689
1,542
1,321
1,046
982
1,111
1,030
1,162
1,150
1,100
1,043
1,040
1,035
989
1,035
938
838
752
717
405
350
324
293
265
241
233
220
128
86
83
81
83
89
95
99
35
62
58
53
48
44
59
54
101
841
1,180
1,130
1,071
3,858
3,707
3,642
3,483
3,346
3,224
3,050
2,854
2,718
2,919
3,175
3,089
2,230
2,401
2,192
1,976
1,817
1,8171,9762,1922,4012,2303,0893,1752,9192,7182,8543,0503,2243,3463,4833,6423,7073,8581,0711,1301,1808411015459444853586235999589838183861282202332412652933243504057177528389381,0359891,0351,0401,0431,1001,1501,1621,0301,1119821,0461,3211,5421,6891,7211,6291,5391,4081,3841,5381,6751,7226,6791,8691,8171,7537,0321,5143,5093,8014,1024,7265,0645,0734,8244,5474,1442,4541,7371,3291,2741,246957681801551407468407398391380481351281288363365
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,913
3,853
2,851
2,168
619
191
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001916192,1682,8513,8536,913000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
281
351
412
380
391
464
475
870
1,358
1,309
1,201
503
5,518
0
27,053
0
0
0
0
13,008
13,454
0
0
0
0
0
0
0
868
0
0
0
712
5,695
5,773
5,687
5,435
5,205
5,639
7,608
5,895
5,891
5,694
5,235
482
1,739
1,953
0
0
0
39
39
0
0
0
0
0
0
0
0
0
0
0
0
204
400
14,660
14,265
13,193
12,772
12,341
11,934
11,670
11,270
16,116
15,722
15,343
14,966
17,655
17,276
16,876
16,535
16,063
15,572
32,209
23,443
22,802
22,537
39,684
37,823
26,121
25,325
31,852
29,875
27,860
25,844
23,829
21,813
13,491
12,849
15,009
14,271
13,531
12,856
12,496
12,136
12,13612,49612,85613,53114,27115,00912,84913,49121,81323,82925,84427,86029,87531,85225,32526,12137,82339,68422,53722,80223,44332,20915,57216,06316,53516,87617,27617,65514,96615,34315,72216,11611,27011,67011,93412,34112,77213,19314,26514,66040020400000000000039390001,9531,7394825,2355,6945,8915,8957,6085,6395,2055,4355,6875,7735,695712000868000000013,45413,008000027,05305,5185031,2011,3091,358870475464391380412351281000
       Long-term Assets Other 
73
145
72
211
70
69
127
130
133
136
602
136
138
7,408
24,335
27,535
36,755
5,588
50,357
53,300
58,892
61,446
48,984
43,020
45,777
41,279
42,036
36,013
34,001
37,732
42,423
31,774
41,301
29,851
28,873
23,820
21,441
29,740
23,628
19,014
17,729
42,331
34,410
32,517
39,900
38,287
34,022
1,786
0
0
0
0
39
0
0
0
0
331
100
381
149
-123
167
-19,372
-17,138
-12,634
-11,703
-11,126
-8,662
-19,684
-17,312
-13,321
-12,858
-12,424
-12,015
-11,753
-14,659
-19,632
-18,952
-18,282
-18,562
-25,714
-26,397
-24,572
-23,082
-21,664
-21,488
-37,510
-28,137
-26,833
-25,835
-41,374
-41,872
-29,828
-28,967
-35,335
-33,221
-31,084
-28,894
-26,683
-24,531
-16,410
1,959
1,792
1,803
1,672
1,073
0
165
16501,0731,6721,8031,7921,959-16,410-24,531-26,683-28,894-31,084-33,221-35,335-28,967-29,828-41,872-41,374-25,835-26,833-28,137-37,510-21,488-21,664-23,082-24,572-26,397-25,714-18,562-18,282-18,952-19,632-14,659-11,753-12,015-12,424-12,858-13,321-17,312-19,684-8,662-11,126-11,703-12,634-17,138-19,372167-12314938110033100003900001,78634,02238,28739,90032,51734,41042,33117,72919,01423,62829,74021,44123,82028,87329,85141,30131,77442,42337,73234,00136,01342,03641,27945,77743,02048,98461,44658,89253,30050,3575,58836,75527,53524,3357,40813813660213613313012769702117214573
> Total Liabilities 
804
871
1,512
1,476
1,476
1,785
1,519
1,497
1,392
1,356
1,271
1,426
1,861
9,544
9,167
16,458
15,863
13,712
18,030
19,429
16,599
9,383
9,461
10,270
9,530
9,451
9,598
8,393
5,259
4,157
2,434
4,208
4,551
3,283
3,092
3,972
4,527
4,162
5,100
5,688
5,737
5,938
9,000
8,609
9,059
11,545
10,318
5,796
25,778
27,018
24,499
24,682
21,794
22,942
18,291
18,631
18,569
20,140
18,966
16,008
16,758
14,612
14,130
6,447
6,286
4,559
4,357
4,390
4,413
7,728
7,852
9,915
10,351
14,479
14,575
12,644
12,830
13,012
11,597
11,492
12,686
16,548
18,119
22,192
21,309
23,884
72,315
76,104
82,366
79,277
78,048
92,721
90,005
96,332
92,978
96,918
94,678
98,361
100,130
101,452
98,510
107,003
113,915
115,831
111,551
110,264
98,390
98,639
96,559
96,55998,63998,390110,264111,551115,831113,915107,00398,510101,452100,13098,36194,67896,91892,97896,33290,00592,72178,04879,27782,36676,10472,31523,88421,30922,19218,11916,54812,68611,49211,59713,01212,83012,64414,57514,47910,3519,9157,8527,7284,4134,3904,3574,5596,2866,44714,13014,61216,75816,00818,96620,14018,56918,63118,29122,94221,79424,68224,49927,01825,7785,79610,31811,5459,0598,6099,0005,9385,7375,6885,1004,1624,5273,9723,0923,2834,5514,2082,4344,1575,2598,3939,5989,4519,53010,2709,4619,38316,59919,42918,03013,71215,86316,4589,1679,5441,8611,4261,2711,3561,3921,4971,5191,7851,4761,4761,512871804
   > Total Current Liabilities 
804
798
864
843
913
1,167
1,012
1,042
862
949
937
1,087
1,585
2,002
1,587
2,623
2,070
2,084
3,503
4,976
5,089
6,091
4,974
5,854
4,858
4,410
4,630
5,495
5,259
4,157
2,434
4,208
4,551
3,283
3,092
3,972
4,527
4,162
5,100
5,688
5,737
5,938
9,000
8,609
9,059
11,545
10,318
5,796
10,950
11,317
10,436
11,738
10,397
13,171
10,064
11,598
12,139
12,979
12,785
11,114
9,728
9,051
9,654
6,447
6,286
4,559
4,357
4,390
4,413
7,728
7,852
9,915
10,351
14,479
14,575
12,644
12,830
13,012
11,597
11,492
12,686
16,548
18,119
22,192
21,309
23,884
23,554
26,871
29,462
25,716
27,440
37,144
31,525
37,548
33,700
41,919
39,300
42,555
44,070
45,076
41,782
49,923
74,495
114,279
72,949
71,316
97,656
47,294
50,246
50,24647,29497,65671,31672,949114,27974,49549,92341,78245,07644,07042,55539,30041,91933,70037,54831,52537,14427,44025,71629,46226,87123,55423,88421,30922,19218,11916,54812,68611,49211,59713,01212,83012,64414,57514,47910,3519,9157,8527,7284,4134,3904,3574,5596,2866,4479,6549,0519,72811,11412,78512,97912,13911,59810,06413,17110,39711,73810,43611,31710,9505,79610,31811,5459,0598,6099,0005,9385,7375,6885,1004,1624,5273,9723,0923,2834,5514,2082,4344,1575,2595,4954,6304,4104,8585,8544,9746,0915,0894,9763,5032,0842,0702,6231,5872,0021,5851,0879379498621,0421,0121,167913843864798804
       Short-term Debt 
0
0
0
0
0
69
63
65
66
68
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,314
0
3,728
0
1,866
1,819
1,805
1,762
1,205
1,158
6
3
1
3,327
6
63
18
17
17
17
74
42
42
15
4,676
0
4,617
0
27
43
70
33
70
363
373
412
425
5,208
5,334
5,427
465
476
479
27,113
65,265
27,439
27,770
57,555
7,707
12,767
12,7677,70757,55527,77027,43965,26527,1134794764655,4275,3345,208425412373363703370432704,61704,67615424274171717186363,3271361,1581,2051,7621,8051,8191,86603,72803,3140000000000000000000000000000000000000000000000000686665636900000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,452
0
0
0
0
0
0
0
0
0
0
0
0
0
26,645
64,789
27,110
27,373
57,143
7,286
12,354
12,3547,28657,14327,37327,11064,78926,64500000000000003,4520000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
804
798
864
843
913
1,167
949
911
795
814
870
1,087
1,585
2,002
1,587
2,623
2,070
2,084
3,503
4,976
5,089
6,091
4,974
5,854
4,858
4,410
4,630
5,495
5,259
4,157
2,434
4,208
4,551
3,283
3,092
3,972
4,527
4,162
5,100
5,688
5,737
5,938
9,000
8,609
9,059
11,545
10,318
5,796
0
0
0
0
0
0
0
0
0
0
2,800
3,321
2,000
1,147
1,623
1,484
639
731
469
480
3,251
5,446
5,096
1,598
6,816
7,030
7,765
2,360
8,750
9,799
8,019
2,319
8,304
12,872
14,172
5,401
15,609
17,190
20,873
15,583
24,312
20,633
21,780
13,106
24,783
30,606
30,827
17,510
30,603
33,180
35,300
15,526
35,924
43,555
41,076
12,886
34,083
33,605
30,457
6,990
29,888
29,8886,99030,45733,60534,08312,88641,07643,55535,92415,52635,30033,18030,60317,51030,82730,60624,78313,10621,78020,63324,31215,58320,87317,19015,6095,40114,17212,8728,3042,3198,0199,7998,7502,3607,7657,0306,8161,5985,0965,4463,2514804697316391,4841,6231,1472,0003,3212,80000000000005,79610,31811,5459,0598,6099,0005,9385,7375,6885,1004,1624,5273,9723,0923,2834,5514,2082,4344,1575,2595,4954,6304,4104,8585,8544,9746,0915,0894,9763,5032,0842,0702,6231,5872,0021,5851,0878708147959119491,167913843864798804
       Other Current Liabilities 
0
0
0
0
0
-69
0
65
0
68
67
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,549
5,030
4,182
5,264
3,875
6,677
3,605
4,882
5,139
8,594
8,411
3,649
5,416
3,746
3,719
3,096
3,828
2,023
2,126
2,706
5
2,276
2,753
8,316
208
7,444
6,748
10,266
4,063
3,196
3,561
9,099
4,341
3,634
3,932
16,791
5,700
6,694
2,681
11,261
5,107
5,013
5,627
23,968
6,342
6,541
2,412
23,934
3,439
4,013
3,315
29,031
5,328
5,835
6,252
36,090
11,389
9,903
9,606
32,559
7,553
7,55332,5599,6069,90311,38936,0906,2525,8355,32829,0313,3154,0133,43923,9342,4126,5416,34223,9685,6275,0135,10711,2612,6816,6945,70016,7913,9323,6344,3419,0993,5613,1964,06310,2666,7487,4442088,3162,7532,27652,7062,1262,0233,8283,0963,7193,7465,4163,6498,4118,5945,1394,8823,6056,6773,8755,2644,1825,0305,549000000000000000000000000000000000000067680650-6900000
   > Long-term Liabilities 
0
73
648
632
562
618
506
456
530
407
335
340
276
7,542
7,580
13,835
13,792
11,628
14,526
14,453
11,510
3,292
4,487
4,416
4,671
5,041
4,967
2,898
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,828
15,701
14,063
12,944
11,398
9,771
8,227
7,034
6,429
7,161
6,181
4,894
7,030
5,561
4,476
7,307
2,305
1,833
1,345
1,569
1,203
11,912
11,793
11,761
12,644
9,372
10,086
9,877
9,869
7,986
7,362
7,927
9,447
6,167
3,486
3,524
3,539
0
48,762
49,233
49,590
49,968
50,349
50,741
51,133
51,553
51,972
52,403
52,834
53,291
53,752
54,227
54,701
55,203
39,420
1,552
38,602
38,948
734
51,345
46,313
46,31351,34573438,94838,6021,55239,42055,20354,70154,22753,75253,29152,83452,40351,97251,55351,13350,74150,34949,96849,59049,23348,76203,5393,5243,4866,1679,4477,9277,3627,9869,8699,87710,0869,37212,64411,76111,79311,9121,2031,5691,3451,8332,3057,3074,4765,5617,0304,8946,1817,1616,4297,0348,2279,77111,39812,94414,06315,70114,828000000000000000000002,8984,9675,0414,6714,4164,4873,29211,51014,45314,52611,62813,79213,8357,5807,542276340335407530456506618562632648730
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49,233
52,903
53,315
50,349
55,311
58,451
58,755
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000058,75558,45155,31150,34953,31552,90349,233000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,314
3,593
259
4,836
4,618
4,631
4,646
41
62
68
75
94
98
108
100
106
0
46
50
0
0
00504601061001089894756862414,6464,6314,6184,8362593,5933,3140000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
341
621
649
647
1,959
1,792
0
1,672
1,073
0
0
001,0731,67201,7921,95964764962134100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
10,595
9,215
8,207
7,027
6,043
12,083
11,263
10,938
10,341
13,767
17,597
16,910
18,331
31,501
38,805
38,534
37,114
39,555
59,691
56,014
71,673
75,262
70,696
65,586
65,407
65,738
60,690
54,263
62,368
56,971
56,106
53,020
58,562
47,577
45,948
41,959
38,676
52,964
46,295
38,962
78,824
79,427
71,143
65,944
85,366
72,732
57,838
37,319
36,191
38,017
43,608
40,700
37,086
31,893
29,577
51,648
47,869
42,824
38,835
35,196
29,249
26,989
27,276
14,180
15,507
14,081
11,972
9,471
5,862
6,911
2,865
-447
-1,138
-485
7,112
7,441
7,216
7,349
8,016
8,088
17,985
20,784
25,619
21,653
19,805
22,169
22,623
21,862
20,711
17,667
16,028
9,573
5,029
-500
-7,268
-12,817
23,933
19,178
10,369
504
-8,528
-31,255
-18,060
-22,571
-32,311
-41,531
-41,704
-20,870
-24,568
-24,568-20,870-41,704-41,531-32,311-22,571-18,060-31,255-8,52850410,36919,17823,933-12,817-7,268-5005,0299,57316,02817,66720,71121,86222,62322,16919,80521,65325,61920,78417,9858,0888,0167,3497,2167,4417,112-485-1,138-4472,8656,9115,8629,47111,97214,08115,50714,18027,27626,98929,24935,19638,83542,82447,86951,64829,57731,89337,08640,70043,60838,01736,19137,31957,83872,73285,36665,94471,14379,42778,82438,96246,29552,96438,67641,95945,94847,57758,56253,02056,10656,97162,36854,26360,69065,73865,40765,58670,69675,26271,67356,01459,69139,55537,11438,53438,80531,50118,33116,91017,59713,76710,34110,93811,26312,0836,0437,0278,2079,21510,595
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
287,600
289,600
286,800
275,200
283,800
271,900
284,800
282,741
273,139
271,555
266,252
265,194
253,426
258,658
258,701
246,148
224,475
224,687
219,476
218,328
215,045
222,470
222,144
217,076
232,213
238,169
263,069
254,753
256,603
257,741
255,814
286,828
286,905
287,035
287,035
287,035
287,035
287,312
287,312
287,312
333,369
335,011
335,716
335,752
335,752
335,752
335,762
338,751
338,751
338,751
338,767
363,927
363,427
363,427363,927338,767338,751338,751338,751335,762335,752335,752335,752335,716335,011333,369287,312287,312287,312287,035287,035287,035287,035286,905286,828255,814257,741256,603254,753263,069238,169232,213217,076222,144222,470215,045218,328219,476224,687224,475246,148258,701258,658253,426265,194266,252271,555273,139282,741284,800271,900283,800275,200286,800289,600287,60000000000000000000000000000000000000000000000000000000000
   Retained Earnings -412,572-408,659-403,851-403,105-393,092-382,649-374,556-367,007-344,280-335,248-325,347-315,833-309,436-300,129-294,580-287,812-282,006-277,462-271,007-269,368-266,194-264,966-233,191-235,572-236,798-233,100-237,450-217,386-214,228-208,988-214,128-215,120-207,829-210,887-212,364-225,172-225,613-246,595-255,837-251,748-247,564-255,723-254,280-257,474-257,632-268,561-264,282-254,005-261,841-244,863-256,560-252,842-246,470-230,614-241,658-239,946-236,090-230,841-218,388-224,783-188,715-184,257-200,311-202,722-194,029-177,250-158,203-147,105-127,507-119,635-117,262-111,139-100,793-93,531-87,214-78,392-69,396-79,922-64,019-58,636-55,442-54,639-40,140-35,864-28,505-23,449-18,537-15,742-14,969-13,040-9,746-30,396-32,258-30,748-22,823-25,762-24,051-22,614-21,411-20,617-19,291-18,164-17,021-17,507-16,231-15,320-14,687-13,786-12,568
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,788
9,019
9,262
9,525
10,783
11,147
11,469
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000011,46911,14710,7839,5259,2629,0198,788000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
23,162
23,001
22,894
22,347
22,274
29,589
28,284
29,102
29,632
32,350
37,001
37,486
40,315
55,261
59,591
69,282
69,372
69,950
69,437
69,054
86,642
91,003
89,233
88,966
93,840
101,524
100,752
107,697
116,513
114,146
118,469
131,041
126,101
124,041
131,049
135,490
139,469
164,103
163,557
158,597
206,063
227,057
230,256
243,527
279,410
275,746
258,403
221,277
224,381
261,619
260,552
270,328
272,048
271,507
270,412
281,707
294,108
295,237
294,759
279,615
290,667
280,551
291,182
-429
-423
-308
-240
-250
-193
-122
-76
-57
-552
-526
-929
-1,141
-1,307
-903
-919
-1,369
-1,168
-1,737
1,028
80
178
-126
-333
95
63
28
-12
-21
-29
4
466
481
-3,872
-3,648
-4,046
-4,427
50
-117
20,109
20,942
21,568
22,280
22,794
23,178
23,834
23,83423,17822,79422,28021,56820,94220,109-11750-4,427-4,046-3,648-3,8724814664-29-21-12286395-333-126178801,028-1,737-1,168-1,369-919-903-1,307-1,141-929-526-552-57-76-122-193-250-240-308-423-429291,182280,551290,667279,615294,759295,237294,108281,707270,412271,507272,048270,328260,552261,619224,381221,277258,403275,746279,410243,527230,256227,057206,063158,597163,557164,103139,469135,490131,049124,041126,101131,041118,469114,146116,513107,697100,752101,52493,84088,96689,23391,00386,64269,05469,43769,95069,37269,28259,59155,26140,31537,48637,00132,35029,63229,10228,28429,58922,27422,34722,89423,00123,162



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-11-30)

Gross Profit (+$)
totalRevenue81,764
Cost of Revenue-19,635
Gross Profit62,12962,129
 
Operating Income (+$)
Gross Profit62,129
Operating Expense-72,756
Operating Income-10,627-10,627
 
Operating Expense (+$)
Research Development30,370
Selling General Administrative15,617
Selling And Marketing Expenses26,769
Operating Expense72,75672,756
 
Net Interest Income (+$)
Interest Income769
Interest Expense-10,361
Other Finance Cost-996
Net Interest Income-10,588
 
Pretax Income (+$)
Operating Income-10,627
Net Interest Income-10,588
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-23,536-8,306
EBIT - interestExpense = -21,215
-23,536
-13,596
Interest Expense10,361
Earnings Before Interest and Taxes (EBIT)-10,854-13,175
Earnings Before Interest and Taxes (EBITDA)-7,539
 
After tax Income (+$)
Income Before Tax-23,536
Tax Provision-421
Net Income From Continuing Ops-23,957-23,957
Net Income-23,957
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses92,391
Total Other Income/Expenses Net-2,32110,588
 

Technical Analysis of Theratech
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Theratech. The general trend of Theratech is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Theratech's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Theratechnologies Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.64 < 1.7 < 1.75.

The bearish price targets are: 1.17 > 1.08 > 1.08.

Tweet this
Theratechnologies Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Theratechnologies Inc.. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Theratechnologies Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Theratechnologies Inc.. The current macd is 0.03131884.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Theratech price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Theratech. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Theratech price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Theratechnologies Inc. Daily Moving Average Convergence/Divergence (MACD) ChartTheratechnologies Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Theratechnologies Inc.. The current adx is 26.80.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Theratech shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Theratechnologies Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Theratechnologies Inc.. The current sar is 1.30870624.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Theratechnologies Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Theratechnologies Inc.. The current rsi is 52.19. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Theratechnologies Inc. Daily Relative Strength Index (RSI) ChartTheratechnologies Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Theratechnologies Inc.. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Theratech price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Theratechnologies Inc. Daily Stochastic Oscillator ChartTheratechnologies Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Theratechnologies Inc.. The current cci is 38.17.

Theratechnologies Inc. Daily Commodity Channel Index (CCI) ChartTheratechnologies Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Theratechnologies Inc.. The current cmo is 2.2372531.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Theratechnologies Inc. Daily Chande Momentum Oscillator (CMO) ChartTheratechnologies Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Theratechnologies Inc.. The current willr is -69.56521739.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Theratech is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Theratechnologies Inc. Daily Williams %R ChartTheratechnologies Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Theratechnologies Inc..

Theratechnologies Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Theratechnologies Inc.. The current atr is 0.10011951.

Theratechnologies Inc. Daily Average True Range (ATR) ChartTheratechnologies Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Theratechnologies Inc.. The current obv is 1,856,556.

Theratechnologies Inc. Daily On-Balance Volume (OBV) ChartTheratechnologies Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Theratechnologies Inc.. The current mfi is 53.81.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Theratechnologies Inc. Daily Money Flow Index (MFI) ChartTheratechnologies Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Theratechnologies Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-06-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-06-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Theratechnologies Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Theratechnologies Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.193
Ma 20Greater thanMa 501.312
Ma 50Greater thanMa 1001.293
Ma 100Greater thanMa 2001.366
OpenGreater thanClose1.362
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Theratech with someone you think should read this too:
  • Are you bullish or bearish on Theratech? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Theratech? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Theratechnologies Inc.

I send you an email if I find something interesting about Theratechnologies Inc..


Stay informed about Theratechnologies Inc..

Receive notifications about Theratechnologies Inc. in your mailbox!